KELVIN BURTON: Open Payments
NPI 1487687331 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$326 in 16 payments from 11 companies in 2025. Trend: 2023 $635 · 2024 $532 · 2025 $326
Food & beverage: $326
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $79 |
| Lilly USA, LLC | 2 | $53 |
| Exact Sciences Corporation | 2 | $33 |
| Novo Nordisk Inc | 1 | $24 |
| Abbott Laboratories | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: JARDIANCE, OTEZLA, REPATHA, Cologuard Collection Kit, PROCLAIM, Belbuca, OPSUMIT, REXULTI.
Industry payments across GA — which companies pay providers there.
